rethinkPeptides Search
Menu
RethinkPeptides

Research library — page 11

Browse more peptide research, methods and limitations.

Filter by topic, method, and evidence

You can select more than one topic or evidence level.

Clear filters

RPEP-00574 · 2000

Neuropeptide Y Promotes Sleep and Reduces Stress Hormones in Young Men

Intranasal NPY promoted sleep and reduced ACTH and cortisol in healthy young men, demonstrating CRH-opposing anxiolytic and sedative effects with potential therapeutic applications for depression and insomnia.

Antonijevic, I A; Murck, H; Bohlhalter, S; Frieboes, R M; Holsboer, F; Steiger, A · RCT

RPEP-00575 · 2000

Tiny Arginine-Rich Peptides That Block Tumor Blood Supply and Slow Cancer Spread

Arginine-rich hexapeptides identified from peptide libraries blocked VEGF from binding to its receptor (IC50 = 2–4 micromolar) and selectively inhibited VEGF-driven blood vessel growth without toxicity to normal cells. In animal models, the peptides stopped new blood vessel formation in both chick membrane and rabbit cornea assays. Most notably, one hexapeptide (RRKRRR) blocked both the growth and spread of human colon cancer cells implanted in mice.

Bae, D G; Gho, Y S; Yoon, W H; Chae, C B · Preclinical

RPEP-00578 · 2000

What Part of Ghrelin Is Essential: Just the First Four Amino Acids With a Fat Tail

The minimal active ghrelin fragment is the first 4 amino acids (GSSF) with octanoyl modification on Ser3; the fatty acid modification is essential while most of the 28-residue chain is dispensable for receptor activation.

Bednarek, M A; Feighner, S D; Pong, S S; McKee, K K; Hreniuk, D L; Silva, M V; Warren, V A; Howard, A D; Van Der Ploeg, L H; Heck, J V · In Vitro

RPEP-00585 · 2000

GH Secretagogue Receptors Found in Both Normal and Cancerous Human Thyroid Tissue

Specific GHS binding sites were detected in normal and neoplastic human thyroid tissue, with highest density in medullary thyroid carcinoma, suggesting GH secretagogues may affect thyroid biology and that GHS-R could serve as a thyroid cancer marker.

Cassoni, P; Papotti, M; Catapano, F; Ghè, C; Deghenghi, R; Ghigo, E; Muccioli, G · In Vitro

RPEP-00587 · 2000

Nesiritide for Acute Heart Failure: The Landmark Trial That Proved a Natriuretic Peptide Could Treat Decompensated Hearts

In the efficacy trial, nesiritide infused at 0.015 and 0.030 μg/kg/min reduced pulmonary-capillary wedge pressure by 6.0 and 9.6 mmHg respectively, compared to a 2.0 mmHg increase with placebo (p < 0.001). Clinical status improved in 60% and 67% of nesiritide patients versus 14% with placebo (p < 0.001). Dyspnea improved in 57% and 53% versus 12% (p < 0.001), and fatigue improved in 32% and 38% versus 5% (p < 0.001). In the comparative trial, nesiritide's improvements in clinical status, dyspnea, and fatigue were sustained for up to seven days and were comparable to standard intravenous heart failure therapy. The most common adverse effect was dose-related hypotension, which was usually asymptomatic.

Colucci, W S; Elkayam, U; Horton, D P; Abraham, W T; Bourge, R C; Johnson, A D; Wagoner, L E; Givertz, M M; Liang, C S; Neibaur, M; Haught, W H; LeJemtel, T H · Randomized Controlled Trial

RPEP-00588 · 2000

Alpha-MSH and KPV Kill Drug-Resistant Bacteria Including MRSA

Alpha-MSH and KPV demonstrated broad-spectrum antimicrobial activity including against MRSA and drug-resistant organisms, with an anti-Candida mechanism resembling amphotericin B membrane disruption.

Cutuli, M; Cristiani, S; Lipton, J M; Catania, A · In Vitro

RPEP-00591 · 2000

Thymosin Alpha-1 in Cancer: From Lab Bench to Patient Bedside

Thymosin alpha-1 combined with low-dose IFN or IL-2 shows high efficacy against cancers in both preclinical models and human clinical trials, supporting its role as a cancer immunotherapy adjuvant.

Garaci, E; Pica, F; Rasi, G; Favalli, C · Review

RPEP-00592 · 2000

New Circular Peptides From Squash Seeds: Tiny Enzyme Blockers With Drug Potential

Three macrocyclic trypsin inhibitors (MCoTI-I, -II, -III) from Momordica cochinchinensis are the smallest known naturally cyclic peptides, with atypical backbone cyclization and potent trypsin inhibition.

Hernandez, J F; Gagnon, J; Chiche, L; Nguyen, T M; Andrieu, J P; Heitz, A; Trinh Hong, T; Pham, T T; Le Nguyen, D · In Vitro

RPEP-00599 · 2000

BNP Spikes Dramatically During Heart Procedures, Signaling Acute Cardiac Stress

BNP increased acutely and much more prominently than ANP during coronary angioplasty, with serial changes correlating with procedural myocardial stress, confirming BNP as the superior acute cardiac biomarker.

Kyriakides, Z S; Markianos, M; Michalis, L; Antoniadis, A; Nikolaou, N I; Kremastinos, D T · Cohort

RPEP-00600 · 2000

Low Oxygen Triggers Blood-Brain Barrier Cells to Produce More Adrenomedullin

Hypoxia induced coordinated upregulation of adrenomedullin and its receptor RDC-1 in brain astrocytes and endothelial cells, with NF-κB-mediated transcriptional activation, suggesting an autocrine/paracrine protective mechanism at the blood-brain barrier.

Ladoux, A; Frelin, C · In Vitro

RPEP-00605 · 2000

Adrenomedullin: A Blood Vessel Peptide That Dilates From Both Sides

Adrenomedullin dilates blood vessels through dual mechanisms — direct smooth muscle relaxation and endothelial NO release — with autocrine/paracrine production by vascular endothelial and smooth muscle cells.

Minamino, N; Kangawa, K; Matsuo, H · Review

RPEP-00607 · 2000

Soldiers With Higher NPY Levels Handle Extreme Military Stress Better

Special forces soldiers showed higher plasma NPY during extreme stress and faster post-stress recovery compared to regular troops, with higher NPY correlating with better performance and less psychological distress.

Morgan, C A; Wang, S; Southwick, S M; Rasmusson, A; Hazlett, G; Hauger, R L; Charney, D S · Cohort

RPEP-00608 · 2000

AOD9604: The Growth Hormone Fragment That Burned Fat in Rats Without Insulin Side Effects

Oral AOD9604 — a synthetic peptide fragment based on the fat-burning region of human growth hormone — reduced weight gain by over 50% in obese Zucker rats. Treated animals gained only 15.8 g versus 35.6 g in controls over 19 days of daily oral dosing at 500 µg/kg body weight. Fat tissue from treated animals showed increased lipolytic (fat-breaking) activity. Critically, unlike full-length growth hormone (which is known to worsen insulin resistance with chronic use), AOD9604 showed no adverse effects on insulin sensitivity when tested with euglycemic clamp techniques — considered the gold standard for measuring insulin action. This separation of fat-burning benefits from growth hormone's diabetogenic side effects was the key finding.

Ng, F M; Sun, J; Sharma, L; Libinaka, R; Jiang, W J; Gianello, R · Animal Study

RPEP-00609 · 2000

Two Natural Opioid Peptides Relieve Pain Through Different Brain Pathways

Endomorphin-2 produces analgesia through both direct mu-opioid receptor activation and indirect dynorphin A release activating kappa receptors via descending pain pathways, while endomorphin-1 uses only the mu pathway.

Ohsawa, M; Mizoguchi, H; Narita, M; Chu, M; Nagase, H; Tseng, L F · Animal Study

RPEP-00610 · 2000

BNP Blood Tests Predict Heart Damage From Cancer Chemotherapy

Persistent BNP elevation after anthracycline chemotherapy predicted development of cardiotoxicity, distinguishing at-risk patients from those with only transient, benign BNP rises.

Okumura, H; Iuchi, K; Yoshida, T; Nakamura, S; Takeshima, M; Takamatsu, H; Ikeno, A; Usuda, K; Ishikawa, T; Ohtake, S; Matsuda, T · Cohort

RPEP-00612 · 2000

Designing Smaller CCK Peptides That Trigger Satiety for Obesity Treatment

Hybrid CCK-A agonist peptides combining structural features of hexapeptide and tetrapeptide classes showed potent receptor binding and selectivity, advancing design of satiety-inducing peptide drugs for obesity.

Pierson, M E; Comstock, J M; Simmons, R D; Julien, R; Kaiser, F; Rosamond, J D · In Vitro

RPEP-00617 · 2000

Estrogen Changes How Growth Hormone Peptides Work in Postmenopausal Women

Oral estradiol supplementation in postmenopausal women modulated continuous GHRP-2-driven GH secretion, increasing IGF-1 response but altering GH pulse dynamics, revealing estrogen-GH secretagogue interactions important for clinical dosing.

Shah, N; Evans, W S; Bowers, C Y; Veldhuis, J D · RCT

RPEP-00620 · 2000

BPC-157 Heals Stomach Damage Caused by Complete Dopamine System Shutdown

Complete dopamine system failure (combined haloperidol + reserpine) produced severe gastric lesions. BPC-157 provided superior healing compared to ranitidine, atropine, and other agents while also reducing associated catalepsy.

Sikiric, P; Separovic, J; Buljat, G; Anic, T; Stancic-Rokotov, D; Mikus, D; Duplancic, B; Marovic, A; Zoricic, I; Prkacin, I; Lovric-Bencic, M; Aralica, G; Ziger, T; Perovic, D; Jelovac, N; Dodig, G; Rotkvic, I; Mise, S; Seiwerth, S; Turkovic, B; Grabarevic, Z; Petek, M; Rucman, R · Animal Study

RPEP-00621 · 2000

BPC-157 Shows Antidepressant Effects in Two Standard Depression Models

BPC-157 showed antidepressant activity in both the Porsolt forced swim test (reduced immobility) and chronic unpredictable stress model in rats, with effects comparable to established antidepressants.

Sikiric, P; Separovic, J; Buljat, G; Anic, T; Stancic-Rokotov, D; Mikus, D; Marovic, A; Prkacin, I; Duplancic, B; Zoricic, I; Aralica, G; Lovric-Bencic, M; Ziger, T; Perovic, D; Rotkvic, I; Mise, S; Hanzevacki, M; Hahn, V; Seiwerth, S; Turkovic, B; Grabarevic, Z; Petek, M; Rucman, R · Animal Study

RPEP-00622 · 2000

Adenosine Is a Natural Partial Activator of the Growth Hormone Secretagogue Receptor

Adenosine was identified as a partial agonist of the GH secretagogue receptor (GHS-R) from hypothalamic extract fractionation, producing submaximal receptor activation compared to full agonists like ghrelin.

Smith, R G; Griffin, P R; Xu, Y; Smith, A G; Liu, K; Calacay, J; Feighner, S D; Pong, C; Leong, D; Pomés, A; Cheng, K; Van der Ploeg, L H; Howard, A D; Schaeffer, J; Leonard, R J · In Vitro

RPEP-00624 · 2000

When the Heart's Atria Stop Beating: ANP Stays Low While BNP Spikes High

Atrial standstill produced a distinctive natriuretic peptide pattern: normal-to-low ANP (from non-functional atria) with markedly elevated BNP (from stressed ventricles), providing a potential diagnostic biomarker signature.

Suguta, M; Hara, K; Nakano, A; Amano, A; Hasegawa, A; Kurabayashi, M · Case Report

RPEP-00628 · 2000

Blocking Angiotensin Receptors Reduces Inflammation Markers and BNP in Heart Failure

Valsartan (angiotensin II type 1 receptor blocker) reduced TNF-α, IL-6, soluble ICAM-1, and BNP in heart failure patients, demonstrating anti-inflammatory effects of angiotensin blockade beyond hemodynamic improvements.

Tsutamoto, T; Wada, A; Maeda, K; Mabuchi, N; Hayashi, M; Tsutsui, T; Ohnishi, M; Sawaki, M; Fujii, M; Matsumoto, T; Kinoshita, M · RCT